Últimos testes

EudraCT Number: 2006-002161-39

Sponsor Protocol Number: CV185-034

Start Date: 2006-12-05

Sponsor Name: Bristol-Myers Squibb International Corporation

Full Title: A Phase 3 Randomized, Double-Blind, Active-Controlled (Enoxaparin), Parallel Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Kne...

Medical condition: Subjects undergoing elective total knee replacement surgery

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DK (Completed) SE (Completed) HU (Completed)

Trial results: View results

EudraCT Number: 2006-000556-41

Sponsor Protocol Number: 106789

Start Date: 2006-12-05

Sponsor Name: GlaxoSmithKline Biologicals

Full Title: An open, phase IV, single-group multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B vaccine challenge in children at 4-5...

Medical condition: Antibody persistence and hepatitis B vaccine challenge in children at 4-5 years of age, previously primed and boosted with 4 doses of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine in routine vaccinatio...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2006-005772-41

Sponsor Protocol Number: LIMIT phase 2 version 1.0

Start Date: 2006-12-05

Sponsor Name: investigator-driven research: Erasmus MC, Neurovascular Section

Full Title: LIMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trial

Medical condition: Patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10052426	Glucose intolerance	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-004432-70

Sponsor Protocol Number: ema1-profilC-2006

Start Date: 2006-12-04

Sponsor Name: AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA

Full Title: A multicenter phase II study to evaluate the safety, tolerability and efficacy of caspofungin as prophylactic treatment of invasive fungal infections in patients with acute leukemia undergoing ind...

Medical condition: neutropenia

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10049085		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-003561-13

Sponsor Protocol Number: cro488

Start Date: 2006-12-04

Sponsor Name: imperial college

Full Title: Reversal of steroid insensitivity in COPD by theophylline

Medical condition: Chronic Obstructive Pulmonary Disease (COPD)

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2006-003149-17

Sponsor Protocol Number: NSCLC-TRT-Avastin

Start Date: 2006-12-04

Sponsor Name: VU University Medical Center

Full Title: Phase I study of concurrent with involved-field thoracic radiotherapy for inoperable non-squamous cell lung cancer, followed by both concurrent and maintenance Bevacizumab

Medical condition: Patients with locally advanced (stages II-IIIB) non-small cell lung cancer who are eligible for high-dose radiotherapy following the completion of induction systemic chemotherapy.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NL (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002832-10

Sponsor Protocol Number: FOXA-1

Start Date: 2006-12-04

Sponsor Name: Haukeland University Hospital

Full Title: Liitännäishoitona annetun oksaliplatiinipohjaisen solusalpaajahoidon jälkeinen hedelmällisyys kolorektaalisyöpäpotilailla. Pohjoismainen prospektiivinen tutkimus. Fertility in colorectal cancer pat...

Medical condition: Kolorektaalisyöpä, colorectal cancer

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: FI (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-001763-36

Sponsor Protocol Number: CSPP100A2347

Start Date: 2006-12-04

Sponsor Name: Novartis Pharma Services AG

Full Title: A randomized, double-blind, parallel-group, placebo-controlled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in st...

Medical condition: Hypertension

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age:

Gender: Male, Female

Trial protocol: NL (Completed) SE (Completed) CZ (Completed) BE (Completed) DE (Completed) HU (Completed)

Trial results: View results

EudraCT Number: 2006-004632-69

Sponsor Protocol Number: P060309

Start Date: 2006-12-04

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: Polymorphismes du gène codant pour le cytochrome 2C19 et réponse au clopidogrel chez le sujet sain

Medical condition: volontaire sain

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10043414	Therapeutic response decreased	PT

Population Age: Adults

Gender: Male

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002060-26

Sponsor Protocol Number: 1401201

Start Date: 2006-12-04

Sponsor Name: Intendis GmbH

Full Title: A double-blind, randomized, vehicle-controlled, 6-week exploratory multicenter pilot study of the efficacy and safety of Azelaic Acid (AzA) 15% gel in the topical treatment of mild to moderate seb...

Medical condition: Patients with mild to moderate seborrheic dermatitis of the facial area and meeting the specific eligibility criteria

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10012488	Dermatitis seborrheic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

Últimos testes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas